Targeted Therapy and Immunotherapy for Non-small Cell Lung Cancer with Brain Metastasis
10.3779/j.issn.1009-3419.2016.08.08
- VernacularTitle:非小细胞肺癌脑转移的靶向和免疫治疗
- Author:
SONG QI
1
;
JIAO SHUNCHANG
;
LI FANG
Author Information
1. 解放军总医院肿瘤内一科
- Keywords:
Lung neoplasms;
Brain metastasis;
Immunotherapy;
Targeted therapy
- From:
Chinese Journal of Lung Cancer
2016;19(8):530-532
- CountryChina
- Language:Chinese
-
Abstract:
Brain metastasis, a common complication of non-small cell lung cancer (NSCLC) with an incidence rate of 30%-50%, signiifcantly affects the patients’ quality of life. hTe prognosis of patients of NSCLC with brain metastasis is ex-tremely poor, the average median survival is only 1 m-2 m without treatment. hTe targeted therapy based on lung cancer driven gene is a new treatment. Besides, the immunotherapy which can enhance the effect of anti-cancer by simulating the immune system is a new approach. The combination of targeted therapy and immunotherapy can greatly benefit patients in clinical work.
